Literature DB >> 33410127

The cytosolic tryparedoxin peroxidase from Trypanosoma cruzi induces a pro-inflammatory Th1 immune response in a peroxidatic cysteine-dependent manner.

Lucía López1,2, María Laura Chiribao2,3, Magalí C Girard4, Karina A Gómez4, Paula Carasi1, Marisa Fernandez5, Yolanda Hernandez5, Carlos Robello2,3, Teresa Freire1, María Dolores Piñeyro2,3.   

Abstract

Trypanosoma cruzi cytosolic tryparedoxin peroxidase (c-TXNPx) is a 2-Cys peroxiredoxin (Prx) with an important role in detoxifying host cell oxidative molecules during parasite infection. c-TXNPx is a virulence factor, as its overexpression enhances parasite infectivity and resistance to exogenous oxidation. As Prxs from other organisms possess immunomodulatory properties, we studied the effects of c-TXNPx in the immune response and analysed whether the presence of the peroxidatic cysteine is necessary to mediate these properties. To this end, we used a recombinant c-TXNPx and a mutant version (c-TXNPxC52S) lacking the peroxidatic cysteine. We first analysed the oligomerization profile, oxidation state and peroxidase activity of both proteins by gel filtration, Western blot and enzymatic assay, respectively. To investigate their immunological properties, we analysed the phenotype and functional activity of macrophage and dendritic cells and the T-cell response by flow cytometry after injection into mice. Our results show that c-TXNPx, but not c-TXNPxC52S, induces the recruitment of IL-12/23p40-producing innate antigen-presenting cells and promotes a strong specific Th1 immune response. Finally, we studied the cellular and humoral immune response developed in the context of parasite natural infection and found that only wild-type c-TXNPx induces proliferation and high levels of IFN-γ secretion in PBMC from chronic patients without demonstrable cardiac manifestations. In conclusion, we demonstrate that c-TXNPx possesses pro-inflammatory properties that depend on the presence of peroxidatic cysteine that is essential for peroxidase activity and quaternary structure of the protein and could contribute to rational design of immune-based strategies against Chagas disease.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Trypanosoma cruzizzm321990; immune response; peroxiredoxin

Mesh:

Substances:

Year:  2021        PMID: 33410127      PMCID: PMC8044337          DOI: 10.1111/imm.13302

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  56 in total

Review 1.  Peroxidases of trypanosomatids.

Authors:  Helena Castro; Ana M Tomás
Journal:  Antioxid Redox Signal       Date:  2008-09       Impact factor: 8.401

2.  Peroxiredoxin-2 and STAT3 form a redox relay for H2O2 signaling.

Authors:  Mirko C Sobotta; Willy Liou; Sarah Stöcker; Deepti Talwar; Michael Oehler; Thomas Ruppert; Annette N D Scharf; Tobias P Dick
Journal:  Nat Chem Biol       Date:  2014-11-24       Impact factor: 15.040

3.  A prime-boost immunization with Tc52 N-terminal domain DNA and the recombinant protein expressed in Pichia pastoris protects against Trypanosoma cruzi infection.

Authors:  Marina N Matos; Andrés Sánchez Alberti; Celina Morales; Silvia I Cazorla; Emilio L Malchiodi
Journal:  Vaccine       Date:  2016-05-10       Impact factor: 3.641

4.  Transforming growth factor-beta1 induces the non-classical secretion of peroxiredoxin-I in A549 cells.

Authors:  Jong Wook Chang; Seung Hee Lee; Yan Lu; Yung Joon Yoo
Journal:  Biochem Biophys Res Commun       Date:  2006-04-27       Impact factor: 3.575

5.  Oligomerization dynamics and functionality of Trypanosoma cruzi cytosolic tryparedoxin peroxidase as peroxidase and molecular chaperone.

Authors:  María Dolores Piñeyro; Diego Arias; Alejandro Ricciardi; Carlos Robello; Adriana Parodi-Talice
Journal:  Biochim Biophys Acta Gen Subj       Date:  2019-06-29       Impact factor: 3.770

6.  Chagas disease: a Latin American health problem becoming a world health problem.

Authors:  Gabriel A Schmunis; Zaida E Yadon
Journal:  Acta Trop       Date:  2009-11-20       Impact factor: 3.112

Review 7.  Immune system recognition of Trypanosoma cruzi.

Authors:  Rick L Tarleton
Journal:  Curr Opin Immunol       Date:  2007-07-24       Impact factor: 7.486

8.  Two enzymes in one; two yeast peroxiredoxins display oxidative stress-dependent switching from a peroxidase to a molecular chaperone function.

Authors:  Ho Hee Jang; Kyun Oh Lee; Yong Hun Chi; Bae Gyo Jung; Soo Kwon Park; Jin Ho Park; Jung Ro Lee; Seung Sik Lee; Jeong Chan Moon; Jeong Won Yun; Yeon Ok Choi; Woe Yeon Kim; Ji Seoun Kang; Gang-Won Cheong; Dae-Jin Yun; Sue Goo Rhee; Moo Je Cho; Sang Yeol Lee
Journal:  Cell       Date:  2004-05-28       Impact factor: 41.582

9.  Class-Switch Recombination Occurs Infrequently in Germinal Centers.

Authors:  Jonathan A Roco; Luka Mesin; Sebastian C Binder; Christian Nefzger; Paula Gonzalez-Figueroa; Pablo F Canete; Julia Ellyard; Qian Shen; Philippe A Robert; Jean Cappello; Harpreet Vohra; Yang Zhang; Carla R Nowosad; Arien Schiepers; Lynn M Corcoran; Kai-Michael Toellner; Jose M Polo; Michael Meyer-Hermann; Gabriel D Victora; Carola G Vinuesa
Journal:  Immunity       Date:  2019-07-30       Impact factor: 31.745

10.  Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.

Authors:  Augusto E Bivona; Andrés Sánchez Alberti; Marina N Matos; Natacha Cerny; Alejandro C Cardoso; Celina Morales; Germán González; Silvia I Cazorla; Emilio L Malchiodi
Journal:  PLoS Negl Trop Dis       Date:  2018-03-30
View more
  2 in total

1.  ClearColi as a platform for untagged pneumococcal surface protein A production: cultivation strategy, bioreactor culture, and purification.

Authors:  Valdemir M Cardoso; Sheyla A H Paredes; Gilson Campani; Viviane M Gonçalves; Teresa C Zangirolami
Journal:  Appl Microbiol Biotechnol       Date:  2022-01-13       Impact factor: 4.813

2.  Role of the Redox State of Human Peroxiredoxin-5 on Its TLR4-Activating DAMP Function.

Authors:  Mégane A Poncin; Pierre Van Meerbeeck; Joshua D Simpson; André Clippe; François Tyckaert; Fabrice Bouillenne; Hervé Degand; André Matagne; Pierre Morsomme; Bernard Knoops; David Alsteens
Journal:  Antioxidants (Basel)       Date:  2021-11-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.